https://ana-12antagonist.com/o....rganic-neuroprotecta
PEG-asparaginase treatment regimens in children and adolescents (under 18) with first-line ALL undergoing multiagent chemotherapy, including PEG-asparaginase, were compared in randomized controlled trials (RCTs) that we included. A standardized data collection form guided two independent review authors in the process of screening, selecting, and extracting data from relevant studies. Each outcome's risk of bias was assessed using the RoB 20 tool, and the GRADE approach was used to gauge the certainty of evidence for
Like
Comment
Share
